Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial. (Record no. 21141672)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02700 a2200769 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516053957.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201203s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1432-0843 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s00280-011-1730-9 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Skarlos, P |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20120320 |
| 245 00 - TITLE STATEMENT | |
| Title | Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer chemotherapy and pharmacology |
| Date of publication, distribution, etc. | Feb 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 533-46 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemotherapy, Adjuvant |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Trials, Phase III as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cluster Analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Estrogen Receptor alpha |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Estrogen Receptor beta |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunohistochemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Outcome Assessment, Health Care |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptor, ErbB-2 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, Estrogen |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, Progesterone |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Reverse Transcriptase Polymerase Chain Reaction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Translational Research, Biomedical |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Christodoulou, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kalogeras, K T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eleftheraki, A G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bobos, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Batistatou, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Valavanis, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tzaida, O |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Timotheadou, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kronenwett, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wirtz, R M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kostopoulos, I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Televantou, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Koutselini, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Papaspirou, I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Papadimitriou, C A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pectasides, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gogas, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aravantinos, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pavlidis, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Arapantoni, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Skarlos, D V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fountzilas, G |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer chemotherapy and pharmacology |
| Related parts | vol. 69 |
| -- | no. 2 |
| -- | p. 533-46 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s00280-011-1730-9">https://doi.org/10.1007/s00280-011-1730-9</a> |
| Public note | Available from publisher's website |
No items available.